Piramal Enterprises Ltd. News and Updates

Name: Latest research reports of Piramal Enterprises Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Piramal Enterprises Ltd.
Rating: 5
Author: Motilal Oswal

Keep track of all breaking news on Piramal Enterprises Ltd. from all sources in a single place.

Load latest

Piramal Enterprises Ltd.

15 Dec 2020

1124.20

-0.65%

Consumer Finance segment to be the next growth driver

Buy: Piramal Enterprises Ltd.

Target

Motilal Oswal

Four products launched; INR500m disbursements in the first month The company launched four retail lending products in Nov'20 LAP, affordable housing finance, mass housing finance, and small business loans (refer Exhibit 1). It also plans to reduce the focus on affluent housing finance. The idea is to have products that banks typically do not focus on and where NBFCs have higher pricing power due to their niche capabilities. PIEL is currently present in 40 locations (14 hub and 26 spoke locations), with an employee strength of over 400 people. Half of its employees are frontline sales persons. In the first month, it disbursed INR500m across these four products....

Piramal Enterprises Ltd. has gained 26.65% in the last 3 Months

Piramal Enterprises Ltd.

29 Oct 2020

1124.20

-0.65%

Three directors quit Piramal Entreprises board to aid succession planning

Business Standard

Keki Dadiseth, Dr. R.A. Mashelkar and Prof. Goverdhan Mehta, independent directors on the board of Piramal Enterprises have resigned, the company informed BSE

Piramal Enterprises Ltd. has gained 49.06% in the last 1 Year

Piramal Enterprises Q2 profit rises 14% to 628 crore

Business Line | 28 Oct 2020 1 more

Piramal Enterprises Ltd.

25 Sep 2020

1124.20

-0.65%

LIC Housing invests in SPR City, Piramal Enterprises exits from project

Business Standard

The company's Director Chetan Bohra said that the capital raised would be utilised for advacing the construction and ensuring the completion of the residential project within this financial year

Piramal Enterprises Ltd. is trading above all available SMAs

Stock recommendations by Anand Rathi: Sell Piramal Enterprises, L&T; Finance

Business Standard | 25 Sep 2020

Piramal Enterprises Ltd.

16 Sep 2020

1124.20

-0.65%

Blackstone, Partners Group in race to buy Piramal Glass

livemint

The investment firms have progressed to the final round of bidding for Piramal Glass Ltd.Piramal Enterprises has been raising funds through debt issues as well as weighing sales of some of its non-core units

Piramal Enterprises Ltd. has gained 26.65% in the last 3 Months

Piramal Enterprises Ltd.

12 Sep 2020

1124.20

-0.65%

CCI nod to Piramal Pharma's 20% stake sale deal with Carlyle group

Business Today

Carlyle picked up a 20 per cent stake in Piramal Enterprises subsidiary Piramal Pharma for Rs 3,700 crore; it is one of the largest private equity deals in Indian pharmaceutical sector

Piramal Enterprises Ltd. has gained 26.65% in the last 3 Months

CCI gives approval to Carlyle Group's 20% buy in Piramal Pharma

Business Standard | 12 Sep 2020

Piramal Enterprises Ltd.

30 Aug 2020

1124.20

-0.65%

Using technology to take faster HR decisions

Business Today

"The use of HR analytics is allowing us to gain insights into how to spot and retain talent," says Vikram Bector, President & Chief Human Resources Officer, Piramal Enterprises

Piramal Enterprises Ltd. has gained 26.65% in the last 3 Months

Piramal Enterprises Ltd.

31 Jul 2020

1124.20

-0.65%

Lending business stable; Pharma recovering

Buy: Piramal Enterprises Ltd.

Motilal Oswal

The EBITDA margin contracted considerably to 11% in the quarter (from 21% in FY20) due to lower revenue from Complex Hospital Generics and The deferment of surgeries in the Hospital segment impacted overall performance in PIELs Pharma segment. However, the phase-wise easing of the lockdown is improving the outlook across the CDMO and Complex The company will roll out retail lending products such as LAP and small business loans around the Diwali festival in 1520 towns. The Pharma business is witnessing increased traction, and the recent stake sale has set a benchmark for its valuation. INR34b of the INR37b Pharma stake sale to Carlyle would go back to PIEL. While PIELs Pharma business was impacted by COVID-19, management indicated U-shaped recovery over the next two to three quarters. We keep credit costs elevated over the next two years The Pharma business is witnessing increased traction.

Piramal Enterprises .. has an average target of 1085.00 from 1 broker.

Piramal Enterprises Ltd.

30 Jul 2020

1124.20

-0.65%

Piramal Enterprises Q1 profit up 11% at Rs 496 cr; revenue at Rs 2,937 cr

Business Standard

Consolidated revenue from operations stood at Rs 2,937.34 crore during the quarter under review as against Rs 3,186.82 crore in the same period a year ago

Piramal Enterprises Ltd. has gained 49.06% in the last 1 Year

Piramal Enterprises net profit rises 11% to 495.5 crore in Q1

livemint | 30 Jul 2020 3 more

Piramal Enterprises Ltd.

14 Jul 2020

1124.20

-0.65%

Ajay Piramal seeks hedge funds to rescue half-built homes

Business Line

Piramal Enterprises Ltd scouts for new investors to help raise cash and fund working capital for the real estate projects it lends

Piramal Enterprises Ltd. has gained 49.06% in the last 1 Year

Indian billionaire seeks hedge funds to rescue half-built homes

livemint | 14 Jul 2020

Piramal Enterprises Ltd.

30 Jun 2020

1124.20

-0.65%

Buy Piramal Enterprises; target of Rs 40: Motilal Oswal

Moneycontrol

Motilal Oswal is bullish on Piramal Enterprises recommended buy rating on the stock with a target price of Rs 40 in its research report dated June 28, 2020.